Effect on Satiety-Related Biomarkers of Bar Snacks Containing Chickpea Flour and Pork Protein.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 23 07 2024
revised: 20 08 2024
accepted: 10 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

This project aims to establish the acceptability and satiety of a hybrid snack containing plant protein and a small percentage of animal protein compared to a meat-based snack. Randomised, crossover, double-blind, controlled post-prandial trial involving 24 participants (18-30 years), with two interventions: (a) a hybrid snack containing plant protein derived from chickpeas and 6.6% lean high-quality pork meat; and (b) a meat-based snack containing 90% lean pork meat. General, life-style, sensory acceptability questionnaire, and the following laboratory analyses were performed: lipid profile, endocannabinoids, and related compounds. Sensory questionnaires showed in general good acceptability for both bars. Additionally, there was a greater increase in glycemia at 30, 60, and 90 min after consuming the hybrid snack compared to the meat-based snack, with no changes in the lipid profile. Regarding the endocannabinoid compounds and related compounds, the compound N-palmitoleoyl ethanolamine in the acylethanolamide group showed higher levels overall following the consumption of the hybrid snack compared to the meat-based snack, particularly at 2 h. The hybrid snack was associated with changes in endocannabinoid-like compounds. Therefore, it may provide a lasting satiating effect, while complementing the protein profile of plant-based foods with the quality of animal protein.

Identifiants

pubmed: 39339780
pii: nu16183180
doi: 10.3390/nu16183180
pii:
doi:

Substances chimiques

Biomarkers 0
Endocannabinoids 0
Blood Glucose 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Auteurs

María-Dolores Zomeño (MD)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Blanquerna School of Health Sciences, Universitat Ramon Llull, 08025 Barcelona, Spain.

Mireia Malcampo (M)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Karla Alejandra Pérez-Vega (KA)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Antoni Pastor (A)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Maria López-Roura (M)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Begoña Arrufat (B)

Fertinagro Biotech S.L., 44195 Teruel, Spain.

Sergio Atarés (S)

Fertinagro Biotech S.L., 44195 Teruel, Spain.

Sergio José Ramos (SJ)

Naturuel S.L., 44002 Teruel, Spain.

David Alonso (D)

Naturuel S.L., 44002 Teruel, Spain.

Isaac Subirana (I)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Blanquerna School of Health Sciences, Universitat Ramon Llull, 08025 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Cardiovascular Diseases (CIBERcv), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Daniel Muñoz-Aguayo (D)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Gemma Blanchart (G)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Sònia Gaixas (S)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Marta Cabañero (M)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Epidemiology and Public Health (CIBEResp), Carlos III Health Institute, 28029 Madrid, Spain.

Susanna Tello (S)

Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Valentini Konstantinidou (V)

DNANUTRICOACH®-Nutrigenetics Center, 16674 Athens, Greece.

Javier Hernando-Redondo (J)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Albert Goday (A)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Medicine, Autonomous University of Barcelona, 08193 Barcelona, Spain.

Olga Castañer (O)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Epidemiology and Public Health (CIBEResp), Carlos III Health Institute, 28029 Madrid, Spain.

Helmut Schröder (H)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Epidemiology and Public Health (CIBEResp), Carlos III Health Institute, 28029 Madrid, Spain.

Montserrat Fitó (M)

Hospital del Mar Research Institute, 08003 Barcelona, Spain.
Consortium Center for Biomedical Research Network (CIBER), M.P. Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH